Deutsche Bank reiterates a 'buy' on British American Tobacco ahead of FY2025 results while forecasting modest organic growth and weaker headline metrics: reported revenue down 1.6% to £25.45bn (organic +2.0%), adjusted profit from operations down 1.3% to £11.22bn, margins down ~190bps to 44.1%, and adjusted diluted EPS down 3.1% to 330.7p (consensus 338.5p). The bank expects adjusted net debt to rise £665m to £31.25bn (2.6x EBITDA), keeps a 4,900p target, and flags investor focus on New Categories (Deutsche forecasts 6.6% CC growth), combustible segment dynamics (Doral/pricing), traction for Glo Hilo, VELO user/expansion metrics, and US regulatory risk around illicit vapes; shares were quoted at 4,531p, up 0.8%.
Market structure: Deutsche’s forecast (reported rev -1.6% to £25.45bn, organic +2%, EPS -3.1% to 330.7p, margins -190bp to 44.1%, net debt +£665m to £31.25bn ~2.6x EBITDA) implies near-term revenue resilience from New Categories but margin-led earnings compression. Winners: NGP/VELO platform owners (BAT/BTI) if mid-single-digit organic growth sustains; losers: low-end combustible players in US deep-discount where pricing pressure persists. Cross-asset: modestly higher corporate credit spreads for BAT-rated debt if leverage drifts >2.8x; GBP could weaken on conservative guidance, while commodity/nicotine input risks appear limited. Risk assessment: Tail risks include aggressive US regulation on illicit vapes or a Glo Hilo rollout failure (high-impact, low-probability) that could knock 10-25% off NGV revenue forecasts; covenant/credit risk if net debt/EBITDA breaches ~3.0x within 12 months. Immediate (days) — earnings reaction volatility; short-term (weeks) — guidance parsing and analyst revisions; long-term (quarters) — ability to sustain mid-single-digit New Categories growth. Hidden dependency: VELO/user retention metrics and Japan Glo Hilo traction are gating factors for valuation re-rating. Trade implications: Favor structured, limited-risk long exposure to BTI (LSE:BATS/NYSE:BTI) to capture DB’s 4,900p thesis while protecting downside via call-spreads or long-dated calls; size tactically 2–3% portfolio. Use pair trades (long BTI / short IMB.L) to isolate NGP execution, and consider buying 3–6 month put protection if post-results guidance signals margin slip >150bp. Rotate modestly out of lower-quality combustible names into resilient consumer staples with cleaner balance sheets. Contrarian angles: Consensus underweights execution optionality in New Categories — a sustained 5–7% organic growth trajectory would justify valuation >4,900p and compress spreads; conversely market may be underpricing regulatory tail risk in US illicit vape rulings. Historical parallels: tobacco re-ratings are driven by NGP adoption curves (PM/Altria precedents) — early user-growth inflection can produce sharp upside. Unintended consequence: aggressive cost-saving to protect dividends could impair NGP investment, slowing medium-term revenue replacement.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment